Combination therapy with intraventricular interferon-α and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay
- 1 August 2003
- journal article
- case report
- Published by Elsevier in Brain & Development
- Vol. 25 (5) , 367-369
- https://doi.org/10.1016/s0387-7604(03)00017-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (13670793)
This publication has 10 references indexed in Scilit:
- Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitisPediatric Neurology, 2001
- Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR AssayJournal of Clinical Microbiology, 1999
- The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivoAntiviral Research, 1998
- Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferonNeurology, 1997
- Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitisAntimicrobial Agents and Chemotherapy, 1996
- Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variabilityVirus Research, 1995
- Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitisNeurology, 1992
- Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitroAntiviral Research, 1989
- INOSIPLEX THERAPY IN SUBACUTE SCLEROSING PANENCEPHALITISThe Lancet, 1982
- Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with inosiplexAnnals of Neurology, 1982